James M. Hoffman
St. Jude Children's Research Hospital · 140 works · 7,597 citations · h-index 45
Top works
- Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
- Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
- Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process
- National survey on the effect of oncology drug shortages on cancer care
- Economic Evaluations of Clinical Pharmacy Services: 2006–2010
- The Second Victim Experience and Support Tool: Validation of an Organizational Resource for Assessing Second Victim Effects and the Quality of Support Resources
- NCCN Biosimilars White Paper: Regulatory, Scientific, and Patient Safety Perspectives
- The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later
- Intravenous Zanamivir for Oseltamivir-Resistant 2009 H1N1 Influenza
- PG4KDS: A model for the clinical implementation of pre‐emptive pharmacogenetics
- Medication Errors Caused by Confusion of Drug Names
- Development and use of active clinical decision support for preemptive pharmacogenomics
- Projecting future drug expenditures—2012
- Development and implementation of a pharmacist-managed clinical pharmacogenetics service
- Economic Evaluations of Clinical Pharmacy Services: 2001–2005
- Patient Safety Culture and the Second Victim Phenomenon: Connecting Culture to Staff Distress in Nurses
- A Clinician-Driven Automated System for Integration of Pharmacogenetic Interpretations Into an Electronic Medical Record
- Projecting future drug expenditures—2009
- The Effects of the Second Victim Phenomenon on Work-Related Outcomes: Connecting Self-Reported Caregiver Distress to Turnover Intentions and Absenteeism
- Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 Update